SCHEMBL25086366

SCHEMBL25086366

CC(C)(C)C1Cc2ccc(N3CCCC3=O)cc2C1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
PDK2 Q15119 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
TP53 P04637 1/20 0.41
MEN1 O00255 2/20 0.41
GAA P10253 1/20 0.41
AKR1C3 P42330 3/20 0.40
BACE1 P56817 1/20 0.40
BRD9 Q9H8M2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23519752 0.84 CYP3A4 (0.50) ALDH1A1KMT2AHPGDCYP3A4CYP2C9
SCHEMBL11114523 0.77 ALDH1A1 (0.54) ALDH1A1KMT2AKDM4EHPGDCYP3A4
SCHEMBL25086303 0.76 TERT (0.39) ALDH1A1KMT2AKDM4EPDK2CYP1A2
SCHEMBL3349457 0.74 GRIA2 (0.57) CYP1A2
SCHEMBL8257459 0.72 HPGD (0.51) ALDH1A1KMT2AKDM4EHPGDCYP3A4
SCHEMBL3872052 0.72 ESR2 (0.56) ALDH1A1KMT2AHPGDCYP3A4CYP2C9
SCHEMBL8262713 0.72 ALDH1A1 (0.49) ALDH1A1KMT2AKDM4EHPGDCYP3A4
SCHEMBL11142367 0.71 ALDH1A1 (0.74) ALDH1A1HPGDCYP3A4CYP2C9CYP1A2
Hydrochloric Acid SCHEMBL3878146 0.71 ALDH1A1 (0.47) ALDH1A1KMT2AKDM4EHPGDCYP3A4
SCHEMBL20929548 0.70 NR1H2 (0.65) ALDH1A1KMT2AHPGDCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230069174-A1 NITROGEN-CONTAINING HETEROCYCLIC AUTOTAXIN INHIBITOR, AND COMPOSITION CONTAINING SAME AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230069174-A1 NITROGEN-CONTAINING HETEROCYCLIC AUTOTAXIN INHIBITOR, AND COMPOSITION CONTAINING SAME AND USE THEREOF ENPP2, NMT2, NMT1 ALDH1A1 4631/4885KMT2A 2849/4885KDM4E 4075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.